应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01244 3D MEDICINES
休市中 07-26 16:08:20
3.900
+0.090
+2.36%
最高
4.040
最低
3.810
成交量
59.45万
今开
4.010
昨收
3.810
日振幅
6.04%
总市值
10.07亿
流通市值
10.07亿
总股本
2.58亿
成交额
231.61万
换手率
0.23%
流通股本
2.58亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
3D MEDICINES盘中异动 早盘大幅拉升5.22%
自选股智能写手 · 07-26 09:34
3D MEDICINES盘中异动 早盘大幅拉升5.22%
3D MEDICINES(01244)股价上升5.249%,现价港币$4.01
阿斯达克财经 · 07-26 09:34
3D MEDICINES(01244)股价上升5.249%,现价港币$4.01
3D MEDICINES盘中异动 大幅上涨6.73%
自选股智能写手 · 07-22
3D MEDICINES盘中异动 大幅上涨6.73%
3D MEDICINES(01244)下跌5.05%,报4.14元/股
金融界 · 07-16
3D MEDICINES(01244)下跌5.05%,报4.14元/股
3D MEDICINES盘中异动 临近收盘大幅跳水5.07%
自选股智能写手 · 07-16
3D MEDICINES盘中异动 临近收盘大幅跳水5.07%
思路迪医药CEO龚兆龙:肿瘤慢病化,让患者更有生存质量
时代财经 · 07-12
思路迪医药CEO龚兆龙:肿瘤慢病化,让患者更有生存质量
3D MEDICINES(01244)下跌5.36%,报4.41元/股
金融界 · 07-08
3D MEDICINES(01244)下跌5.36%,报4.41元/股
3D MEDICINES盘中异动 早盘急速下挫5.15%报4.420港元
自选股智能写手 · 07-08
3D MEDICINES盘中异动 早盘急速下挫5.15%报4.420港元
新药研发迎重大利好!国常会审议通过:全链条支持创新药发展
南方都市报 · 07-05
新药研发迎重大利好!国常会审议通过:全链条支持创新药发展
港股异动 | 3D MEDICINES-B(01244)盘中跌超5% 股价创新低 市值较高点蒸发超九成
智通财经 · 07-05
港股异动 | 3D MEDICINES-B(01244)盘中跌超5% 股价创新低 市值较高点蒸发超九成
3D MEDICINES(01244)下跌5.01%,报4.55元/股
金融界 · 07-05
3D MEDICINES(01244)下跌5.01%,报4.55元/股
3D MEDICINES盘中异动 股价大跌5.01%
自选股智能写手 · 07-05
3D MEDICINES盘中异动 股价大跌5.01%
3D MEDICINES盘中异动 快速下挫5.73%报4.620港元
自选股智能写手 · 07-03
3D MEDICINES盘中异动 快速下挫5.73%报4.620港元
3D MEDICINES(01244)下跌5.07%,报5.06元/股
金融界 · 07-02
3D MEDICINES(01244)下跌5.07%,报5.06元/股
3D MEDICINES盘中异动 早盘股价大跌5.07%
自选股智能写手 · 07-02
3D MEDICINES盘中异动 早盘股价大跌5.07%
3D MEDICINES(01244)下跌5.14%,报5.35元/股
金融界 · 06-27
3D MEDICINES(01244)下跌5.14%,报5.35元/股
3D MEDICINES盘中异动 股价大跌5.14%
自选股智能写手 · 06-27
3D MEDICINES盘中异动 股价大跌5.14%
3D MEDICINES(01244)股价下跌5.142%,现价港币$5.35
阿斯达克财经 · 06-27
3D MEDICINES(01244)股价下跌5.142%,现价港币$5.35
3D MEDICINES盘中异动 急速拉升5.11%
自选股智能写手 · 06-20
3D MEDICINES盘中异动 急速拉升5.11%
3D MEDICINES盘中异动 股价大跌9.26%
自选股智能写手 · 06-11
3D MEDICINES盘中异动 股价大跌9.26%
公司概况
公司名称:
3D MEDICINES
所属市场:
SEHK
上市日期:
--
主营业务:
3D Medicines Biotechnology Shanghai Co Ltd 是一家中国公司,主要从事商业化肿瘤产品和候选药物的研发。该公司的主要产品管线包括免疫肿瘤单一疗法、作用机制适合在管线内组合的候选药物以及疼痛管理资产。该公司核心产品为皮下注射抗PD-L1药物恩沃利单抗。该公司还有多个处于临床阶段的候选药物,包括肽癌疫苗3D189、GAS6诱饵受体3D229、成纤维细胞生长因子受体(FGFR)3D185等。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01244","market":"HK","secType":"STK","nameCN":"3D MEDICINES","latestPrice":3.9,"timestamp":1721981300022,"preClose":3.81,"halted":0,"volume":594500,"delay":0,"floatShares":258207000,"shares":258207000,"eps":-2.4699142,"marketStatus":"休市中","marketStatusCode":7,"change":0.09,"latestTime":"07-26 16:08:20","open":4.01,"high":4.04,"low":3.81,"amount":2316060,"amplitude":0.060367,"askPrice":3.92,"askSize":2500,"bidPrice":3.9,"bidSize":32500,"shortable":3,"etf":0,"ttmEps":-2.4699141133542546,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722216600000},"adr":0,"listingDate":1671033600000,"adjPreClose":3.81,"openAndCloseTimeList":[[1721957400000,1721966400000],[1721970000000,1721980800000]],"volumeRatio":1.978742086851671,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01244/wiki","defaultTab":"wiki","newsList":[{"id":"2454888359","title":"3D MEDICINES盘中异动 早盘大幅拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454888359","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454888359?lang=zh_cn&edition=full","pubTime":"2024-07-26 09:34","pubTimestamp":1721957673,"startTime":"0","endTime":"0","summary":"2024年07月26日早盘09时34分,3D MEDICINES股票出现波动,股价急速上涨5.22%。截至发稿,该股报4.010港元/股,成交量7000股,换手率0.00%,振幅0.00%。3D MEDICINES股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,3D MEDICINES、科笛-B、云康集团涨幅较大,振幅较大的相关个股有巨子生物、康希诺生物、康诺亚-B,振幅分别为5.04%、4.23%、3.61%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726093433941fac0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726093433941fac0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2454438356","title":"3D MEDICINES(01244)股价上升5.249%,现价港币$4.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2454438356","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454438356?lang=zh_cn&edition=full","pubTime":"2024-07-26 09:34","pubTimestamp":1721957640,"startTime":"0","endTime":"0","summary":"[上升股]3D MEDICINES(01244) 股价在上午09:34比前收市价上升5.249%,现股价为港币$4.01。至目前为止,今日最高价为$4.01,而最低价为$4.01。总成交量为7000股,总成交金额为港币$2.807万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240726255/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2453179784","title":"3D MEDICINES盘中异动 大幅上涨6.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453179784","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453179784?lang=zh_cn&edition=full","pubTime":"2024-07-22 11:27","pubTimestamp":1721618841,"startTime":"0","endTime":"0","summary":"2024年07月22日早盘11时27分,3D MEDICINES股票出现波动,股价快速拉升6.73%。截至发稿,该股报4.280港元/股,成交量14.45万股,换手率0.06%,振幅8.48%。3D MEDICINES股票所在的生物技术行业中,整体涨幅为1.22%。其相关个股中,华领医药-B、科济药业-B、帝王国际投资涨幅较大,振幅较大的相关个股有华领医药-B、科伦博泰生物-B、维亚生物,振幅分别为15.70%、9.01%、7.07%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722112721af93585b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722112721af93585b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2451952189","title":"3D MEDICINES(01244)下跌5.05%,报4.14元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451952189","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451952189?lang=zh_cn&edition=full","pubTime":"2024-07-16 15:56","pubTimestamp":1721116583,"startTime":"0","endTime":"0","summary":"7月16日,3D MEDICINES(01244)盘中下跌5.05%,截至15:56,报4.14元/股,成交254.26万元。3D Medicines Inc.是一家专注于肿瘤治疗领域的医药公司,主要业务是为全球肿瘤患者开发肿瘤药物,产品线包括12款具有临床价值的创新候选药物。公司目前拥有约250人的新药研发、生产和商业化的团队,其中8款药物已进入临床开发或商业化阶段,包括已获国家药品监督管理局批准在中国上市的恩维达,以及已获FDA批准开展全球III期临床研究的3D189和3D229。截至2023年年报,3D MEDICINES营业总收入6.35亿元、净利润-5.25亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/16155641593945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2451190952","title":"3D MEDICINES盘中异动 临近收盘大幅跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451190952","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451190952?lang=zh_cn&edition=full","pubTime":"2024-07-16 15:56","pubTimestamp":1721116578,"startTime":"0","endTime":"0","summary":"2024年07月16日临近收盘15时56分,3D MEDICINES股票出现波动,股价急速跳水5.07%。截至发稿,该股报4.140港元/股,成交量60.5万股,换手率0.23%,振幅5.73%。3D MEDICINES股票所在的生物技术行业中,整体涨幅为0.14%。其相关个股中,亚盛医药-B、维亚生物、百奥赛图-B涨幅较大,振幅较大的相关个股有维亚生物、宜明昂科-B、圣诺医药-B,振幅分别为17.00%、16.14%、14.89%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161556199681d261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161556199681d261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2450328593","title":"思路迪医药CEO龚兆龙:肿瘤慢病化,让患者更有生存质量","url":"https://stock-news.laohu8.com/highlight/detail?id=2450328593","media":"时代财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450328593?lang=zh_cn&edition=full","pubTime":"2024-07-12 10:02","pubTimestamp":1720749748,"startTime":"0","endTime":"0","summary":"本文来源:时代财经 作者:张羽岐 编者按:近年来,中国生物医药产业全球崛起,势不可挡。本土创新药开始登上世界舞台,与欧美强敌同台竞技,中国市场也由此成为全球医药产业链上举足轻重的一环。2024年,时代传媒推出全新深度访谈栏目《寻药中国·时代Bio20人》,围绕中国创新药发展的荣光、困境和破局,与业界领袖对话...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/O8YcpJs2wcS7jToxCiU8KKoSoJnhBmi4bMDlgasvZUbggAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O8YcpJs2wcS7jToxCiU8KKoSoJnhBmi4bMDlgasvZUbggAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240712A025NX00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240712A025NX00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["09939","BK1515","BK1161","BK1574","01244"],"gpt_icon":0},{"id":"2449716503","title":"3D MEDICINES(01244)下跌5.36%,报4.41元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449716503","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449716503?lang=zh_cn&edition=full","pubTime":"2024-07-08 10:26","pubTimestamp":1720405582,"startTime":"0","endTime":"0","summary":"7月8日,3D MEDICINES(01244)盘中下跌5.36%,截至10:26,报4.41元/股,成交108.46万元。3D Medicines Inc.是一家专注于肿瘤治疗领域的医药公司,主要业务是为全球肿瘤患者开发肿瘤药物,产品线包括12款具有临床价值的创新候选药物。公司目前拥有约250人的新药研发、生产和商业化的团队,其中8款药物已进入临床开发或商业化阶段,包括已获国家药品监督管理局批准在中国上市的恩维达,以及已获FDA批准开展全球III期临床研究的3D189和3D229。截至2023年年报,3D MEDICINES营业总收入6.35亿元、净利润-5.25亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/08102641425707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2449371987","title":"3D MEDICINES盘中异动 早盘急速下挫5.15%报4.420港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449371987","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449371987?lang=zh_cn&edition=full","pubTime":"2024-07-08 10:26","pubTimestamp":1720405568,"startTime":"0","endTime":"0","summary":"2024年07月08日早盘10时26分,3D MEDICINES股票出现异动,股价快速下跌5.15%。截至发稿,该股报4.420港元/股,成交量22.15万股,换手率0.09%,振幅5.15%。资金方面,该股资金流入52.538万港元,流出31.959万港元。3D MEDICINES股票所在的生物技术行业中,整体跌幅为1.41%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708102608aef8561a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708102608aef8561a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2449294123","title":"新药研发迎重大利好!国常会审议通过:全链条支持创新药发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2449294123","media":"南方都市报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449294123?lang=zh_cn&edition=full","pubTime":"2024-07-05 23:59","pubTimestamp":1720195147,"startTime":"0","endTime":"0","summary":"据新华社消息,7月5日,国务院总理李强主持召开国务院常务会议,审议通过《全链条支持创新药发展实施方案》。央视截图。近几年国内创新药投资一度进入低谷期,业内不断呼吁加大政策支持。虽然文件尚未公开发布,但已有人将之形容为“新药研发重大利好”!这并不是该文件首次引起业内注目。今年3月中旬,一份同名的征求意见...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/Otp9senA2nzpCc8GfBWEHuz2_DM5lKHAgr9rzXq5x9J9UAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Otp9senA2nzpCc8GfBWEHuz2_DM5lKHAgr9rzXq5x9J9UAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240705A0ANEF00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240705A0ANEF00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1161","BK1574","01244"],"gpt_icon":0},{"id":"2449237074","title":"港股异动 | 3D MEDICINES-B(01244)盘中跌超5% 股价创新低 市值较高点蒸发超九成","url":"https://stock-news.laohu8.com/highlight/detail?id=2449237074","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449237074?lang=zh_cn&edition=full","pubTime":"2024-07-05 15:34","pubTimestamp":1720164862,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,3D MEDICINES-B盘中跌超5%,低见4.53港元创上市以来新低,当前市值较高点已蒸发超九成。截至发稿,跌3.55%,报4.62港元,成交额371.61万港元。消息面上,美国Biotech企业TRACON近日宣布,由于临床试验中恩沃利单抗未达到主要终点,将终止进一步开发。据悉,2019年,思路迪医药与康宁杰瑞制药、TRACON 签署合作协议,共同推研发代号为KN035的恩沃利单抗在北美软组织肉瘤的临床开发与商业化。财报显示,2023年,恩维达的销售收入为6.35亿元,同比增长11.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1146063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01244","HSCEI","07226","BK1161","YANG","HSTECH"],"gpt_icon":0},{"id":"2449286670","title":"3D MEDICINES(01244)下跌5.01%,报4.55元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449286670","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449286670?lang=zh_cn&edition=full","pubTime":"2024-07-05 10:52","pubTimestamp":1720147941,"startTime":"0","endTime":"0","summary":"7月5日,3D MEDICINES(01244)盘中下跌5.01%,截至10:52,报4.55元/股,成交179.57万元。3D Medicines Inc.是一家专注于肿瘤治疗领域的医药公司,主要业务是为全球肿瘤患者开发肿瘤药物,产品线包括12款具有临床价值的创新候选药物。公司目前拥有约250人的新药研发、生产和商业化的团队,其中8款药物已进入临床开发或商业化阶段,包括已获国家药品监督管理局批准在中国上市的恩维达,以及已获FDA批准开展全球III期临床研究的3D189和3D229。截至2023年年报,3D MEDICINES营业总收入6.35亿元、净利润-5.25亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/05105241390402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2449177286","title":"3D MEDICINES盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449177286","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449177286?lang=zh_cn&edition=full","pubTime":"2024-07-05 10:52","pubTimestamp":1720147941,"startTime":"0","endTime":"0","summary":"2024年07月05日早盘10时52分,3D MEDICINES股票出现波动,股价快速跳水5.01%。截至发稿,该股报4.550港元/股,成交量38.7万股,换手率0.15%,振幅3.76%。3D MEDICINES股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,金斯瑞生物科技、东曜药业-B、三叶草生物-B涨幅较大,振幅较大的相关个股有科笛-B、科伦博泰生物-B、泰格医药,振幅分别为8.51%、7.77%、7.06%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070510522196819d21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070510522196819d21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2448453681","title":"3D MEDICINES盘中异动 快速下挫5.73%报4.620港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448453681","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448453681?lang=zh_cn&edition=full","pubTime":"2024-07-03 10:05","pubTimestamp":1719972340,"startTime":"0","endTime":"0","summary":"2024年07月03日早盘10时05分,3D MEDICINES股票出现异动,股价急速下挫5.73%。截至发稿,该股报4.620港元/股,成交量57.75万股,换手率0.22%,振幅7.35%。资金方面,该股资金流入65.843万港元,流出181.913万港元。3D MEDICINES股票所在的生物技术行业中,整体涨幅为0.10%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070310054096819051&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070310054096819051&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2448703699","title":"3D MEDICINES(01244)下跌5.07%,报5.06元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448703699","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448703699?lang=zh_cn&edition=full","pubTime":"2024-07-02 10:53","pubTimestamp":1719888819,"startTime":"0","endTime":"0","summary":"7月2日,3D MEDICINES(01244)盘中下跌5.07%,截至10:53,报5.06元/股,成交241.72万元。3D Medicines Inc.是一家专注于肿瘤治疗领域的医药公司,主要业务是为全球肿瘤患者开发肿瘤药物,产品线包括12款具有临床价值的创新候选药物。公司目前拥有约250人的新药研发、生产和商业化的团队,其中8款药物已进入临床开发或商业化阶段,包括已获国家药品监督管理局批准在中国上市的恩维达,以及已获FDA批准开展全球III期临床研究的3D189和3D229。截至2023年年报,3D MEDICINES营业总收入6.35亿元、净利润-5.25亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/02105341316972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2448703439","title":"3D MEDICINES盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448703439","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448703439?lang=zh_cn&edition=full","pubTime":"2024-07-02 10:53","pubTimestamp":1719888817,"startTime":"0","endTime":"0","summary":"2024年07月02日早盘10时53分,3D MEDICINES股票出现异动,股价快速下挫5.07%。截至发稿,该股报5.060港元/股,成交量46.55万股,换手率0.18%,振幅7.50%。资金方面,该股资金流入54.4095万港元,流出156.213万港元。3D MEDICINES股票所在的生物技术行业中,整体跌幅为0.68%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702105337aef77e74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702105337aef77e74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2446237624","title":"3D MEDICINES(01244)下跌5.14%,报5.35元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446237624","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446237624?lang=zh_cn&edition=full","pubTime":"2024-06-27 11:13","pubTimestamp":1719458039,"startTime":"0","endTime":"0","summary":"6月27日,3D MEDICINES(01244)盘中下跌5.14%,截至11:13,报5.35元/股,成交127.21万元。3D Medicines Inc.是一家专注于肿瘤治疗领域的医药公司,主要业务是为全球肿瘤患者开发肿瘤药物,产品线包括12款具有临床价值的创新候选药物。公司目前拥有约250人的新药研发、生产和商业化的团队,其中8款药物已进入临床开发或商业化阶段,包括已获国家药品监督管理局批准在中国上市的恩维达,以及已获FDA批准开展全球III期临床研究的3D189和3D229。截至2023年年报,3D MEDICINES营业总收入6.35亿元、净利润-5.25亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062711181195dc9622&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062711181195dc9622&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2446244376","title":"3D MEDICINES盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446244376","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446244376?lang=zh_cn&edition=full","pubTime":"2024-06-27 11:13","pubTimestamp":1719458037,"startTime":"0","endTime":"0","summary":"2024年06月27日早盘11时13分,3D MEDICINES股票出现波动,股价大幅跳水5.14%。截至发稿,该股报5.350港元/股,成交量23.35万股,换手率0.09%,振幅5.32%。3D MEDICINES股票所在的生物技术行业中,整体跌幅为1.21%。其相关个股中,盛禾生物-B、复宏汉霖、和铂医药-B涨幅较大,振幅较大的相关个股有帝王国际投资、歌礼制药-B、方达控股,振幅分别为13.33%、12.94%、12.05%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627111357aef6d6eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627111357aef6d6eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2446376905","title":"3D MEDICINES(01244)股价下跌5.142%,现价港币$5.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2446376905","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446376905?lang=zh_cn&edition=full","pubTime":"2024-06-27 11:13","pubTimestamp":1719457980,"startTime":"0","endTime":"0","summary":"[下跌股]3D MEDICINES(01244) 股价在上午11:13比前收市价下跌5.142%,现股价为港币$5.35。至目前为止,今日最高价为$5.65,而最低价为$5.35。总成交量为23.25万股,总成交金额为港币$126.672万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2406272608/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2444269296","title":"3D MEDICINES盘中异动 急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444269296","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444269296?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:29","pubTimestamp":1718868550,"startTime":"0","endTime":"0","summary":"2024年06月20日下午盘15时29分,3D MEDICINES股票出现异动,股价大幅上涨5.11%。截至发稿,该股报6.170港元/股,成交量39.55万股,换手率0.15%,振幅7.16%。3D MEDICINES股票所在的生物技术行业中,整体跌幅为0.81%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。该公司主要在中国国内市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620152910af8e6339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620152910af8e6339&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2442580233","title":"3D MEDICINES盘中异动 股价大跌9.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442580233","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442580233?lang=zh_cn&edition=full","pubTime":"2024-06-11 09:30","pubTimestamp":1718069407,"startTime":"0","endTime":"0","summary":"2024年06月11日早盘09时30分,3D MEDICINES股票出现波动,股价急速跳水9.26%。截至发稿,该股报5.490港元/股,成交量8500股,换手率0.00%,振幅16.69%。3D MEDICINES股票所在的生物技术行业中,整体跌幅为0.12%。其相关个股中,3D MEDICINES、维亚生物、泰格医药涨幅较大,振幅较大的相关个股有泰格医药、昭衍新药、圣诺医药-B,振幅分别为3.05%、1.93%、1.43%。3D MEDICINES公司简介:3D Medicines Inc是一家主要从事生物制药研发及商业化业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611093007af8cd1be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611093007af8cd1be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3d-medicines.com","stockEarnings":[{"period":"1week","weight":-0.0274},{"period":"1month","weight":-0.3085},{"period":"3month","weight":-0.373},{"period":"6month","weight":-0.377},{"period":"1year","weight":-0.9206},{"period":"ytd","weight":-0.4895}],"compareEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":-0.0591},{"period":"3month","weight":-0.0357},{"period":"6month","weight":0.067},{"period":"1year","weight":-0.1333},{"period":"ytd","weight":-0.0015}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3D Medicines Biotechnology Shanghai Co Ltd 是一家中国公司,主要从事商业化肿瘤产品和候选药物的研发。该公司的主要产品管线包括免疫肿瘤单一疗法、作用机制适合在管线内组合的候选药物以及疼痛管理资产。该公司核心产品为皮下注射抗PD-L1药物恩沃利单抗。该公司还有多个处于临床阶段的候选药物,包括肽癌疫苗3D189、GAS6诱饵受体3D229、成纤维细胞生长因子受体(FGFR)3D185等。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"3D MEDICINES","nameEN":"3D MEDICINES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"3D MEDICINES(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供3D MEDICINES(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"3D MEDICINES,01244,3D MEDICINES股票,3D MEDICINES股票老虎,3D MEDICINES股票老虎国际,3D MEDICINES行情,3D MEDICINES股票行情,3D MEDICINES股价,3D MEDICINES股市,3D MEDICINES股票价格,3D MEDICINES股票交易,3D MEDICINES股票购买,3D MEDICINES股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"3D MEDICINES(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供3D MEDICINES(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}